Edwards Lifesciences Corporation
$81.27
▲
1.96%
2026-04-22 10:12:13
www.edwards.com
NYQ: EW
Explore Edwards Lifesciences Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$46.93 B
Current Price
$81.27
52W High / Low
$87.89 / $68.63
Stock P/E
44.98
Book Value
$17.8
Dividend Yield
—
ROCE
13.77%
ROE
10.35%
Face Value
—
EPS
$1.81
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
16,000
Beta
0.94
Debt / Equity
6.82
Current Ratio
3.72
Quick Ratio
3.09
Forward P/E
23.5
Price / Sales
7.45
Enterprise Value
$41.71 B
EV / EBITDA
23.24
EV / Revenue
6.87
Rating
Buy
Target Price
$96.93
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 2. | Catheter Precision, Inc. | $0.97 | — | $2.63 M | — | -43.77% | -1.92% | $15.68 / $0.79 | $2.62 |
| 3. | Boston Scientific Corporation | $65.03 | 33.52 | $96.13 B | 0% | 10.39% | 12.45% | $109.5 / $60.59 | $16.34 |
| 4. | ENvue Medical, Inc. | $1.51 | — | $5.59 M | — | -394.93% | -30.51% | $75.48 / $0.99 | $42 |
| 5. | Insulet Corporation | $193.4 | 55.6 | $13.48 B | — | 18.87% | 18.12% | $354.88 / $194.61 | $21.53 |
| 6. | Picard Medical, Inc. | $0.9 | — | $69.69 M | — | -344.07% | 270.74% | $13.68 / $0.9 | $0.05 |
| 7. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.57 B | 1.55 B | 1.53 B | 1.41 B | 1.39 B | — |
| Operating Profit | 370.3 M | 425.1 M | 430.9 M | 409.9 M | 353.3 M | — |
| Net Profit | 91.2 M | 291.1 M | 329.8 M | 358 M | 385.6 M | — |
| EPS in Rs | 0.16 | 0.5 | 0.57 | 0.62 | 0.67 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 6.07 B | 5.44 B | 5.01 B | 4.46 B |
| Operating Profit | 1.64 B | 1.48 B | 1.49 B | 1.54 B |
| Net Profit | 1.07 B | 4.17 B | 1.4 B | 1.52 B |
| EPS in Rs | 1.86 | 7.24 | 2.43 | 2.64 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 13.7 B | 13.06 B | 9.36 B | 8.29 B |
| Total Liabilities | 3.36 B | 2.99 B | 2.64 B | 2.49 B |
| Equity | 10.34 B | 10 B | 6.65 B | 5.81 B |
| Current Assets | 6.74 B | 6.29 B | 4.04 B | 3.1 B |
| Current Liabilities | 1.81 B | 1.51 B | 1.2 B | 1.02 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.6 B | 542.3 M | 895.8 M | 1.22 B |
| Investing CF | -712.9 M | 2.31 B | 173.8 M | 252.3 M |
| Financing CF | -956.8 M | -983 M | -711 M | -1.58 B |
| Free CF | 1.33 B | 259.9 M | 629.5 M | 953.4 M |
| Capex | -260.2 M | -282.4 M | -266.3 M | -264.8 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 8.57% | 12.23% | — | — |
| Earnings Growth % | 197.68% | -7.85% | — | — |
| Profit Margin % | 76.75% | 27.99% | 34.09% | — |
| Operating Margin % | 27.21% | 29.66% | 34.48% | — |
| Gross Margin % | 79.46% | 80.47% | 83.79% | — |
| EBITDA Margin % | 31.68% | 30.64% | 37.6% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.